Medication
Pharmaceutical compound
Cimetidine Pronunciation or Trade names Tagamet, others Other names SKF-92334[ 1] AHFS /Drugs.com Monograph MedlinePlus a682256 License data
Pregnancy category Routes of administration By mouth , intramuscular injection , intravenous infusion [ 2] ATC code Legal status
Bioavailability 60–70%[ 5] [ 6] Protein binding 13–25%[ 6] [ 7] Metabolism Liver [ 6] Metabolites • Cimetidine sulfoxide[ 6] • Hydroxycimetidine[ 6] • Guanyl urea cimetidine[ 6] Onset of action 30 minutes[ 8] Elimination half-life 123 minutes (~2 hours)[ 7] Duration of action 4–8 hours[ 2] Excretion Urine [ 7]
1-cyano-2-methyl-3-[2-[(5-methyl-1H -imidazol-4-yl)methylsulfanyl]ethyl]guanidine
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEBI ChEMBL CompTox Dashboard (EPA ) ECHA InfoCard 100.052.012 Formula C 10 H 16 N 6 S Molar mass 252.34 g·mol−1 3D model (JSmol )
CC1=C(N=CN1)CSCCNC(=NC)NC#N
InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)
Y Key:AQIXAKUUQRKLND-UHFFFAOYSA-N
Y
(verify)
Cimetidine , sold under the brand name Tagamet among others, is a histamine H2 receptor antagonist that inhibits stomach acid production.[ 1] [ 9] [ 10] It is mainly used in the treatment of heartburn and peptic ulcers .[ 1] [ 10] [ 11]
With the development of proton pump inhibitors, such as omeprazole, approved for the same indications, cimetidine is available as an over-the-counter formulation to prevent heartburn or acid indigestion, along with the other H2-receptor antagonists.[ 12]
Cimetidine was developed in 1971 and came into commercial use in 1977.[ 13] [ 14] Cimetidine was approved in the United Kingdom in 1976,[citation needed ] and was approved in the United States by the Food and Drug Administration in 1979.[ 15]
^ a b c Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Bibliographies . Springer. pp. 275–. ISBN 978-1-4757-2085-3 .
^ a b Gupta A, Singh-Radcliff N (12 March 2013). Pharmacology in Anesthesia Practice . Oxford University Press. pp. 177–. ISBN 978-0-19-934399-7 .
^ "Cimetidine tablet, film coated" . DailyMed . 30 November 2022. Retrieved 24 June 2024 .
^ "Tagamet - cimetidine tablet" . DailyMed . 10 June 2024. Retrieved 24 June 2024 .
^ Dowd FJ, Johnson B, Mariotti A (3 September 2016). Pharmacology and Therapeutics for Dentistry - E-Book . Elsevier Health Sciences. pp. 406–. ISBN 978-0-323-44595-5 .
^ a b c d e f Cite error: The named reference LeikinPaloucek1995
was invoked but never defined (see the help page ).
^ a b c Profiles of Drug Substances, Excipients and Related Methodology . Academic Press. 24 October 1984. pp. 176–. ISBN 978-0-08-086108-1 .
^ Cite error: The named reference VallerandSanoski2016
was invoked but never defined (see the help page ).
^ Index Nominum 2000: International Drug Directory . Taylor & Francis. January 2000. pp. 234–. ISBN 978-3-88763-075-1 .
^ a b Morton I, Morton IK, Hall JM (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms . Springer Science & Business Media. pp. 77–. ISBN 978-0-7514-0499-9 .
^ Jacqueline B, Rosenthal L (2 December 2014). "Drugs for Peptic Ulcer Disease" . Lehne's Pharmacology for Nursing Care . Elsevier Health Sciences. pp. 952–. ISBN 978-0-323-34026-7 .
^ Pino MA, Azer SA (March 2023). "Cimetidine" . StatPearls [Internet] . Treasure Island (FL): StatPearls Publishing. PMID 31334975 . Bookshelf ID: NBK544255. Retrieved 6 November 2023 – via U.S. National Library of Medicine.
^ Fischer J, Ganellin CR (24 August 2010). Analogue-based Drug Discovery II . John Wiley & Sons. p. 4. ISBN 978-3-527-63212-1 .
^ Alapi EM, Fischer J (2006). "Table of Selected Analogue Classes" . In Fischer J, Ganellin CR (eds.). Analogue-based Drug Discovery . John Wiley & Sons. p. 444. ISBN 9783527607495 .
^ "Tagamet: FDA-Approved Drugs" . U.S. Food and Drug Administration (FDA) . Retrieved 9 November 2023 .